Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize …

Z Amin, ZM Hijazi, JL Bass… - Catheterization and …, 2004 - Wiley Online Library
The objectives of this study were to identify possible risk factors that may lead to erosion of
the Amplatzer septal occluder (ASO) and recommend ways to minimize future risk. There …

Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder

A Divekar, T Gaamangwe, N Shaikh, M Raabe… - Journal of the American …, 2005 - jacc.org
Objectives: Amplatzer septal occluder (ASO)-associated cardiac perforation (CP) at our
institution prompted this retrospective review. Background: Cardiac perforation is a rare …

Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders

J Masura, P Gavora, T Podnar - Journal of the American College of …, 2005 - jacc.org
Objectives: The aim of this study was to assess long-term results of percutaneous closure of
secundum-type atrial septal defect (ASD II) using Amplatzer septal occluders (ASO) …

[PDF][PDF] 先天性心脏病介入治疗的严重并发症分析及其防治

蒋世良, 黄连军, 徐仲英, 赵世华, 凌坚, 郑宏, 张戈军… - 2005 - docs.cn-healthcare.com
摘要目的: 探讨先天性心脏病(先心病) 介入治疗中和治疗后严重并发症的发生率,
原因及防治措施. 方法: 对2 318 例4 种常见先心病施行了介入治疗, 其中动脉导管未闭(PDA) …

[HTML][HTML] Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal …

DJ DiBardino, DB McElhinney, AK Kaza… - The Journal of thoracic …, 2009 - Elsevier
OBJECTIVE: Amplatzer (AGA Medical Corporation, Plymouth, Minn) septal and vascular
occluder devices have significantly altered the care of patients with congenital heart …

Percutaneous atrial septal occluder devices and cardiac erosion: a review of the literature

GB Crawford, RG Brindis, MW Krucoff… - Catheterization and …, 2012 - Wiley Online Library
Objective To systematically review all cases in the literature of erosion associated with Atrial
Septal Defect (ASD) occluder devices. Background Delayed erosion of the aortic or atrial …

BioSTAR Evaluation Study (BEST) a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal …

MJ Mullen, D Hildick-Smith, JV De Giovanni, C Duke… - Circulation, 2006 - Am Heart Assoc
Background—The use of permanent synthetic implants to close atrial septal defects (ASD)
and patent foramen ovale (PFO) has a number of limitations, including late complications …

Are resorbable implants about to become a reality?

M Peuster, P Beerbaum, FW Bach… - Cardiology in the …, 2006 - cambridge.org
Stents serve a temporary purpose if they are implanted in stenoses not due to compression
or distortion of the treated vessel. If stents are implanted with the indication of treating …

Surgery for complications of trans-catheter closure of atrial septal defects: a multi-institutional study from the European Congenital Heart Surgeons Association

GE Sarris, G Kirvassilis, P Zavaropoulos… - European journal of …, 2010 - academic.oup.com
Objective: This study aims to analyse the collective experience of participating European
Congenital Heart Surgeons Association centres in the surgical management of …

[HTML][HTML] State of the art ASD closure devices for congenital heart

ML O'Byrne, DS Levi - Interventional cardiology clinics, 2019 - ncbi.nlm.nih.gov
The purpose of this review is to describe the current state of the art in terms of available
devices and indications for the transcatheter device closure of atrial septal defects (ASD) …